Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis

The New England Journal of Medicine
Jack D SobelTeng-Chiao Chu

Abstract

No safe and convenient regimen has proved to be effective for the management of recurrent vulvovaginal candidiasis. After inducing clinical remission with open-label fluconazole given in three 150-mg doses at 72-hour intervals, we randomly assigned 387 women with recurrent vulvovaginal candidiasis to receive treatment with fluconazole (150 mg) or placebo weekly for six months, followed by six months of observation without therapy. The primary outcome measure was the proportion of women in clinical remission at the end of the first six-month period. Secondary efficacy measures were the clinical outcome at 12 months, vaginal mycologic status, and time to recurrence on the basis of Kaplan-Meier analysis. Weekly treatment with fluconazole was effective in preventing symptomatic vulvovaginal candidiasis. The proportions of women who remained disease-free at 6, 9, and 12 months in the fluconazole group were 90.8 percent, 73.2 percent, and 42.9 percent, as compared with 35.9 percent, 27.8 percent, and 21.9 percent, respectively, in the placebo group (P< 0.001). The median time to clinical recurrence in the fluconazole group was 10.2 months, as compared with 4.0 months in the placebo group (P<0.001). There was no evidence of fluconazol...Continue Reading

Citations

Oct 18, 2005·Current Infectious Disease Reports·Paul Nyirjesy, Jack D Sobel
Oct 27, 2006·Current Infectious Disease Reports·Carolyn Gardella
Oct 27, 2006·Current Infectious Disease Reports·Jack D Sobel
Dec 14, 2004·The New England Journal of Medicine·Christopher T Kuebrich
Sep 23, 2006·The New England Journal of Medicine·Linda O Eckert
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juan LiFeng-Yan Bai
Oct 27, 2012·AIDS Research and Human Retroviruses·Daniel MerensteinDongmei Li
Nov 16, 2005·Clinical Obstetrics and Gynecology·P Janet Say, Claudia Jacyntho
Jan 25, 2013·Journal of Lower Genital Tract Disease·Henke C Vergers-SpoorenGilbert Donders
May 14, 2008·Current Opinion in Pediatrics·David A Kaufman
Apr 9, 2010·Clinical Microbiology Reviews·Jacqueline M Achkar, Bettina C Fries
Jun 15, 2007·Infection and Immunity·Antonio CassoneGiorgio Santoni
May 6, 2005·Journal of Clinical Microbiology·Sandra S RichterMichael A Pfaller
Sep 8, 2005·Journal of Clinical Microbiology·F FouletS Bretagne
Apr 16, 2010·Medicinski pregled·Suzana Tasić, Natasa Miladinović-Tasić
Sep 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Samantha J EellsLoren G Miller
Sep 1, 2005·Women's Health·Jack Sobel
Mar 17, 2010·Mycopathologia·Norbert Berila, Julius Subik
Dec 23, 2015·Critical Reviews in Microbiology·Bruna GonçalvesSónia Silva
Dec 23, 2006·Expert Review of Vaccines·Antonio Cassone, Antonella Torosantucci
Oct 17, 2015·Pathogens·Flavia De BernardisSandro Norelli
Jul 31, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jong H KimBruce C Campbell
Oct 22, 2008·Expert Opinion on Pharmacotherapy·Alicia Gómez-LópezManuel Cuenca-Estrella
Jun 25, 2014·Drug Delivery·Himmat Singh JohalAmit Kumar Goyal
Sep 2, 2015·Diabetes & Metabolism·P Njomnang SohB Bouhanick
Dec 19, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasJack D Sobel
Aug 14, 2012·Revista iberoamericana de micología·Elisabeth Gomez-MoyanoVicente Crespo Erchiga
Jun 19, 2008·Nursing for Women's Health·Cathy Watson
Jan 31, 2009·Nihon rinsho. Japanese journal of clinical medicine·Fumitake Ono, Shinichiro Yasumoto
Jul 15, 2015·American Journal of Obstetrics and Gynecology·Jack D Sobel
Aug 4, 2009·Best Practice & Research. Clinical Obstetrics & Gynaecology·Phillip Hay, Austin Ugwumadu
Jul 26, 2006·Journal of the Chinese Medical Association : JCMA·Peng-Hui WangChiou-Chung Yuan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.